Chronic Allograft Nephropathy Clinical Trial
Official title:
Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy
The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the development of chronic allograft nephropathy and changes in allograft function in prevalent renal transplant recipients
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01346397 -
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
|
N/A | |
| Recruiting |
NCT00999258 -
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
|
Phase 4 | |
| Completed |
NCT01265615 -
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
|
Phase 4 | |
| Recruiting |
NCT00541814 -
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
|
Phase 4 | |
| Not yet recruiting |
NCT00659620 -
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
|
Phase 1/Phase 2 | |
| Completed |
NCT05682313 -
Validity of Strain Elastography for the Evaluation of Chronic Allograft Nephropathy
|
N/A | |
| Completed |
NCT00975000 -
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
|
Phase 3 | |
| Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
| Completed |
NCT00007787 -
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
|
N/A | |
| Completed |
NCT00005010 -
Prevention of Kidney Transplant Rejection
|
Phase 3 |